9: A Shot (or Two) in the Arm

An in-depth discussion with Evercore ISI analyst Umer Raffat on the coming COVID-19 vaccines, including trials, safety, distribution, and a possible timetable for normalcy. Umer heads Evercore ISI’s large-cap therapeutics research and was inducted in 2020 to the Institutional Investor’s All-America Research Team Hall of Fame.

Posted December 1, 2020

Timestamps

How impressive was it to get COVID-19 vaccines in less than a year? (2:58)

What has been sacrificed in the interest of time? (3:54)

Details on the various vaccine trials (4:33)

How long will the vaccines last? (7:40)

Should people hold off on the vaccine for safety concerns? (9:47)

Why are two shots needed? (10:35)

What are the side effects? (11:20)

Can a vaccinated person still transmit COVID-19? (11:59)

When will vaccinations begin? (14:54)

What potential stumbling blocks do the vaccines face? (16:00)

Has a game-changing approach to vaccines been developed? (16:45)

How long until we know how safe the vaccine is? (18:58)

What does distribution look like? (19:50)

What happens if you take only one of two shots? (21:11)

Who decides who gets the vaccine? (21:43)

What are the major concerns on the path to worldwide vaccinations? (22:46)

What do you say to anti-vaxxers? (23:35)

How long will we be social distancing? (25:15)

How will distribution ramp up? (26:00)

When will herd immunity kick in? (27:08)

What does the world look like beyond 2021? (28:29)

How will we look back at how the pandemic was handled? (29:08)

How should we prepare for the next pandemic? (29:40)

Speed Round (30:12)

  • Would you personally take the vaccine?
  • Should a vaccine be mandatory?
  • Would you recommend kids take the vaccine?
  • When will our country be back to business as usual?

 

 

 

 

 

 

Pacific Asset Management LLC is the sub-adviser for the Pacific Funds Fixed-Income Funds. The views in this commentary are as of December 1, 2020 and are presented for informational purposes only. These views should not be construed as investment advice, an endorsement of any security, mutual fund, sector or index, or to predict performance of any investment. Any forward-looking statements are not guaranteed. All material is compiled from sources believed to be reliable, but accuracy cannot be guaranteed. The opinions expressed herein are subject to change without notice as market and other conditions warrant. Sector names in this commentary are provided by the Funds’ portfolio managers and could be different if provided by a third party.

DOL - Pacific Funds

Pacific Life Insurance Company is the administrator for Pacific Funds. It is not a fiduciary and therefore does not give advice or make recommendations regarding insurance or investment products.

Pacific Funds and Pacific Asset Management LLC are registered service marks of Pacific Life Insurance Company.

PSD2

Pacific Funds are distributed by Pacific Select Distributors, LLC (member FINRA & SIPC), a subsidiary of Pacific Life Insurance Company (Newport Beach, CA), and are available through licensed third parties. Pacific Funds refers to Pacific Funds Series Trust.

For financial professional use only. Not for use with the public.

"Getting Credit" Host:

Dominic Nolan, CFA 
Senior Managing Director  
Pacific Asset Management

More Podcasts

8: The Votes Are In (Pt 2)

Continuing the discussion with lobbyists Seaver Sowers and Allison Shuster from Government Relations at Pacific Life. 

7: The Votes Are In (Pt 1)

Dissecting the 2020 election: Surprises, trends, and what’s next.

6: Retail Therapy

Detailing the seismic shifts in the retail sector and what the future may hold.